top of page

Mwandishi:

ULY CLINIC

Mhariri:

ULY CLINIC

Imeboreshwa;

22 Mei 2026, 03:20:06

Megaloblastic Anemia
Megaloblastic Anemia
Megaloblastic Anemia
Megaloblastic Anemia

Megaloblastic Anemia

Megaloblastic anemia is a macrocytic anemia characterized by ineffective erythropoiesis and the presence of large, structurally abnormal, immature red blood cell precursors (megaloblasts) in the bone marrow.


It is most commonly caused by:

  • Vitamin B12 (cobalamin) deficiency

  • Folate (vitamin B9) deficiency

Both vitamins are essential for DNA synthesis, and their deficiency results in defective nuclear maturation with preserved cytoplasmic development (nuclear–cytoplasmic asynchrony).


Pathophysiology

  • Impaired thymidine synthesis → defective DNA replication

  • Delayed nuclear maturation

  • Ineffective hematopoiesis

  • Intramedullary hemolysis

  • Pancytopenia (in severe cases)

Vitamin B12 deficiency uniquely affects the nervous system, leading to demyelination (subacute combined degeneration).


Risk Factors

Vitamin B12 Deficiency

  • Pernicious anemia (autoimmune intrinsic factor deficiency)

  • Gastrectomy or bariatric surgery

  • Chronic gastritis

  • Malabsorption (Crohn’s disease, celiac disease)

  • Long-term metformin use

  • Strict vegan diet

  • Elderly age

  • Fish tapeworm (Diphyllobothrium latum)


Folate Deficiency

  • Poor dietary intake

  • Chronic alcoholism

  • Pregnancy

  • Hemolytic anemia (increased demand)

  • Malabsorption

  • Methotrexate or anticonvulsant therapy


Signs and Symptoms


General Anemia Features

  • Pallor

  • Fatigue

  • Dyspnea

  • Tachycardia


Characteristic Features

  • Mild jaundice (lemon-yellow tint)

  • Glossitis (beefy red tongue)

  • Hyperpigmentation of palms

  • Hair loss

  • Depression

  • Weight loss


Neurological Features (Vitamin B12 Deficiency)

  • Paresthesia (pins and needles)

  • Numbness (hands and feet)

  • Ataxic gait

  • Loss of vibration and position sense

  • Tremors

  • Peripheral neuropathy

  • Cognitive changes

  • Psychosis (rare)

Neurological symptoms may occur even without severe anemia.


Diagnostic Criteria

Diagnosis is based on:

  1. Macrocytic anemia

  2. Laboratory evidence of B12 or folate deficiency

  3. Characteristic peripheral smear findings

  4. Clinical features


Investigations

Hematological Tests

  • FBC:

    • Low hemoglobin

    • Elevated MCV (>100 fL)

    • Possible pancytopenia

  • Reticulocyte count (usually low initially)

  • Peripheral smear:

    • Oval macrocytes

    • Hypersegmented neutrophils (>5 lobes)


Biochemical Tests

  • Serum vitamin B12

  • Serum folate

  • Red cell folate (more reliable)

  • Elevated LDH

  • Elevated indirect bilirubin

  • Homocysteine (↑ in both B12 and folate deficiency)

  • Methylmalonic acid (↑ only in B12 deficiency)


Additional Tests

  • TSH (exclude hypothyroidism)

  • Urea and electrolytes

  • Liver function tests

  • Anti-intrinsic factor antibodies (pernicious anemia)

  • Bone marrow biopsy (if diagnosis unclear)


Differential Diagnosis

  • Liver disease

  • Hypothyroidism

  • Alcoholism

  • Myelodysplastic syndrome

  • Aplastic anemia

  • Drug-induced macrocytosis


Treatment

Treatment depends on the underlying deficiency.


Non-Pharmacological Management

  • Dietary counseling

  • Alcohol cessation

  • Management of malabsorption

  • Treat underlying gastrointestinal pathology


Pharmacological Management


1. Vitamin B12 Deficiency (Without Neurological Signs)


Hydroxycobalamine (IM) initially 1 mg three times a week for 2 weeks, then 1 mg IM every 3 months.

  • Review the patient’s blood counts and clinical assessment every 3 months.


2. Pernicious Anemia or B12 Deficiency with Neurological Symptoms

Hydroxycobalamine (IM) initially 1 mg on alternate days until no further improvement is achieved (maximum reversal of neuropsychiatric signs and symptoms), then 1 mg every 2–3 months.


AND

A: Folic acid (PO) 5 mg every 24 hours for at least 3 months. This must be started simultaneously with injectable vitamin B12.


AND

A: Ferrous sulphate (PO) 200 mg every 8 hours for at least 3 months.



Important: Always exclude or treat B12 deficiency before giving folate alone, as folate may correct anemia but worsen neurological damage.


Monitoring Response

  • Reticulocyte rise within 5–7 days

  • Hemoglobin improves within 2–3 weeks

  • Full correction in ~2 months

  • Neurological recovery may take months


Complications

  • Irreversible neuropathy (untreated B12 deficiency)

  • Cognitive impairment

  • Subacute combined degeneration

  • Heart failure (severe anemia)

  • Infertility

  • Increased thrombotic risk (elevated homocysteine)


Prevention

  • Balanced diet rich in:

    • Meat, fish, dairy (B12)

    • Leafy greens (folate)

  • Supplementation in:

    • Pregnancy

    • Chronic hemolytic anemia

    • Malabsorption syndromes

  • Lifelong B12 in pernicious anemia

  • Screening high-risk elderly patients


Prognosis

  • Excellent with early treatment

  • Neurological complications reversible if treated promptly

  • Pernicious anemia requires lifelong therapy

References

  1. Hoffbrand AV, Moss PAH. Essential Haematology. 8th ed.

  2. Williams Hematology. 10th ed.

  3. British Society for Haematology (BSH). Guidelines on Vitamin B12 and Folate Deficiency.

  4. World Health Organization (WHO). Nutritional Anemias Report.

  5. National Institute for Health and Care Excellence (NICE). Vitamin B12 Deficiency Guidelines.

  6. UpToDate. Clinical manifestations and diagnosis of vitamin B12 and folate deficiency.

  7. Rodak BF. Hematology: Clinical Principles and Applications.

  8. Bain BJ. Blood Cells: A Practical Guide.

  9. Ministry of Health Standard Treatment Guidelines (STG).

  10. O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients.


Updated on,

14 Novemba 2020, 10:56:36

bottom of page